Restoring Insulin Secretion Adult Medication Study
Latest Information Update: 15 May 2023
At a glance
- Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
- Indications Prediabetic state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RISE Adult
- 12 May 2023 Status changed from active, no longer recruiting to completed.
- 16 Jun 2021 Results from the three RISE study (NCT01779362, NCT01779375 and NCT01763346) assessing the effect of Liraglutide and metformin in adults would improve a-cell function beyond any potential effect of weight loss, published in the Diabetes Care.
- 15 Jun 2021 Results assessing the comparing the glycemic worsening between youth and adult RISE participants with IGT or recently diagnosed type 2 diabetes and identify baseline characteristics that predict glycemic worsening in each group, published in the Diabetes Care.